Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
2,011
Views
0
CrossRef citations to date
0
Altmetric
COVID-19
Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19
Scott Gibsona Coreva Scientific, Koenigswinter, Germany
, Rhodri Saundersa Coreva Scientific, Koenigswinter, Germany
, Nathan Staskob EmitBio, Inc, Durham, NC, USA
, Cherrishe-Brown Bickerstaffc Cardinal Health Specialty Solutions, Dublin, OH, USA
, John Oakleyb EmitBio, Inc, Durham, NC, USA
, Mark Ostermanb EmitBio, Inc, Durham, NC, USA
, Rafael Torrejon Torresa Coreva Scientific, Koenigswinter, Germany
, Jonathan K. Kishc Cardinal Health Specialty Solutions, Dublin, OH, USA
, Bruce A. Feinbergc Cardinal Health Specialty Solutions, Dublin, OH, USA
& David Emersonb EmitBio, Inc, Durham, NC, USACorrespondence[email protected]
show all
Pages 503-514
|
Received 28 Jan 2022, Accepted 16 Mar 2022, Published online: 09 Apr 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.